American Cannabis News

Verano Q2 Revenue Falls 9% – New Cannabis Ventures

Published

6 months ago

August 17, 2025

admin

Verano Q2 Revenue Falls 9% – New Cannabis Ventures

The link announces the 2025 financial results of the second quarter

Chicago, 07, 2025 (Globe Newswire) – SUMMER HOLDINGS CORP. (COE CA: VRNO) (otcqx: VRNOF) (“review” or “review” or “company”) today for the second quarter of its financial results on June 30, 2025, which was prepared for the total accounting principles (“NAS”).

Second quarter 2025 Financial importance

• Revenues: net of discounts, $ 202 million.

• $ 113 million or 56% gross profits.

• SG and costs: $ 86 million or 43% of income.

• $ (19) million dollars or (9)% income.

• adjusted EBITDA¹ $ 66 million or 33% of income.

• Published net cash with operating operations of $ 11 million.

• Capital expenditures: $ 10 million.

Management Comment:

“I am proud of the progress made during the quarter to strengthen our foundation and initiate the main priorities, including improving our actions and improving margins. “During the whole quarter, we have created a profitability of more efficient and efficient crops, off innovation of a new product and improved retail in several main markets.”

Archos concluded.

Second quarter 2025 Financial review

Revenues for the second quarter of 2025 compared to $ 202 million in the second quarter of 2024, the level of income in the second quarter of the previous 2025 action investments.

The gross profit of the second quarter of 2025 was $ 113 million or 56% for the second quarter of 2024, and compared to the second quarter of 2025, it was partially reimbursed from the objects of expanded crops.

The second quarter of the second quarter of SG & 2025 amounted to 86 million dollars or 43% of the income from $ 85 million to $ 85 million or the decline in the second quarter of the second quarter of the income decreased business.

The net loss of the second quarter of 2025 reached $ (19) million or (9)% income, during the second quarter of the second quarter of the second quarter, compared to the second quarter, compared to the previous year, compared to the previous year.

EBITDAI adjusted for the second quarter was $ 66 million or 33% of income.

The net cash for the second quarter of 2025 was $ 11 million, and for the second quarter of 2024, which was mainly attributed to operational efficiency compared to the previous year and last year.

For the second quarter of 2025, capital expenditures amounted to $ 10 million for the second quarter of 2024, and in the first quarter of 2025 – $ 1425.

Second quarter 2025 Operational importance

Suggested and appointed Richard to the Catherine as Chief Financial Officer.
Expanded the company’s retail footprint by opening the following new dispenser.
- Müv ™ New Smyrna Beach, Company 81st Dispensary in Florida; aeration of
- Zen Leaf ™ Ashford and Zen Leaf ™ Enfield, which raises the company’s Connecticut retail actions for seven disseminations.
An exclusive partnership with growing sciences, Charraft Cannabis Award-winning elite genetics award developer, its kit in Illinois market flower and extraction products.
Introduced a retail retail retail in the style of Bodegra, in the “Zen Leaf” cave, located in the Funyx city of Arizona, representing one of the largest products directly available in the United States.

Original press release

Published by NCV NewsWire

NCV NewsWire aims to treat high-quality content and information about cannabis companies by New Cannabis Ventures to help our readers make noise and remain the most important cannabical business news. NCV Newswire is hand treated by hand and is not automated. Have secret news tip. Contact:A number

Related Topics:Cannabis Falls Revenue Ventures Verano

Up Next

Cresco Labs Reports 11% Q2 Revenue Decline – New Cannabis Ventures

Don't Miss

Q2 Cannabis Financial Updates Fail to Impress – New Cannabis Ventures

American Cannabis Coverage by State

Cannabis Sales Slipped in January – New Cannabis Ventures

Published

4 days ago

February 4, 2026

admin

Cannabis Sales Were Soft Again – New Cannabis Ventures

On February 3, 2026 at 8:42 PM

New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s 15-state monthly cannabis sales data.

In January, cannabis sales decreased sequentially by 3.1%. In this review, we break down the results by state, starting with the western markets and then ending with the eastern markets. Overall, the BDSA estimates sales in 15 markets totaled $2.07 billion in January, up 4.6 percent from a year earlier. BDSA updated its Illinois numbers after the state recently changed the way it counts sales.

Western markets

BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In December, annual growth was negative in 4 states. Growth in each of these states fell in succession.

Eastern markets

BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, Ohio and Pennsylvania. Annual growth in December ranged from -3.1% in Missouri to +37.6% in New York. Ohio began using adults in August, spurring growth. Note that Florida and Pennsylvania are medical markets only. On a daily basis, sequential gains declined in eight markets. Annual growth was negative in both markets and sharp in both states. We warned of a potential slowdown in Florida despite strong dispensary and unit volume growth due to competitive pressure.

For readers interested in a deeper look hemp markets in these fifteen states and more, including segmentation by additional product categories, brand and product details, longer history and segmentation by product attributes, learn how BDSA Solutions can give you access to actionable data and analytics.

Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El

In this article.

Arizona, bdsa, California, cannabis data analysis, Colorado, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, New York, Ohio, Oregon, Pennsylvania

4Front

Illinois Provides Another Cannabis Update – New Cannabis Ventures

Published

7 days ago

February 1, 2026

admin

Illinois Cannabis Data Change Suggests Much Lower Sales – New Cannabis Ventures

February 1, 2026 at 3:27 p.m

Illinois released sales figures for two months on Friday. The last time it released the data in November, the state did a major review of historical sales after a long delay, and it was updated to October. The previous report was for Cannabis for adults in May. The November document explained that the lack of data was due to the Metrc transition. “Sales tracking features in Metrc help retailers more accurately and reliably report actual sales, including all discounts and promotions at checkout. A careful review of past data shows that some initial discount prices were collected in previous months.” Here is the updated data until the end of 2025.

Statewide adult cannabis sales rose 5.6% sequentially to $116.6 million in December, up 2.2% on the day. Year-on-year growth was -23.9%, a slight improvement from November’s -26.1% growth. Here is a chart of adult sales over time:

After growing 106% in 2021, 13% in 2022 and 5% in 2023, annual sales for adults are set to grow 5.4% to $1.72 billion in 2024. In 2025, they decreased by 12.5% to $1.51 billion, which was lower than the total in 2022.

There hasn’t been an update from the state on medical cannabis in a while. The state exempts the sale separately from its medical plan, and April issue showed that sales fell 1.6% sequentially to $19.7 million, down 13.2% year over year.

In this article.

4 Front, Aaaaaah, rise to health, ayr health, AYRWF:, Cannabist, cbst:, cbstf:, cl:, Cresco Labs, CRLBF:, treatment, Curaleaf:, curly, flight, ffntf:, Green Thumb Industries, gtbif:, gti:, Illinois, YOU:, jusf, jushi, embodied, mrmd:, Planet 13:, plnh, PLTH:, summer, WITH:, vrnoff:

American Cannabis News

A Very Large MSO Is Now Extending Its Business – New Cannabis Ventures

Published

1 week ago

January 31, 2026

admin

You are reading this week’s edition of New Cannabis Ventures, a weekly magazine we have published since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve, as well as links to the most important news of the week. We no longer email them like we used to, but post this and all newsletters on our website here.

friends,

This week, Scotts Miracle-Gro, the largest stock in the Global Hemp Stock Index by market capitalization, announced that it has found a buyer for its Hawthorne Gardening Company business in Vireo Growth. This news first appeared in an online article published by the Wall Street Journaland then Vireo issued a press release like Scotts Miracle-Gro, which also reported in its fiscal 1st quarter.

The deal is not a done deal. Vireo called it a “non-binding memorandum of understanding” but did not discuss the terms of the deal or when it might close. Scotts Miracle-Gro, which had already told investors it was working on this type of deal, did not disclose Hawthorne’s financial results for the 1st quarter. Analysts didn’t really ask any questions about it during the conference. The WSJ article said Vireo is giving Scotts Miracle-Gro 13% of its stock in return, but neither company has disclosed that in their press releases or SEC filings.

I include SMG in my 420 Investor Focus List, but Vireo is not a member of that group. Vireo also failed to qualify for the Global Cannabis Stock Index due to its low trading volumes. As I detailed five weeks ago, The Vireo has grown very large in terms of revenue and its geographic focus. The stock was then at $0.625 and is now lower, closing at $0.55. On Christmas Eve, the decline was 12.0%, while the MSOS fell 10.1%.

Maybe investors are interested in this deal and I’m not. First, it’s not a done deal. Second, to purchase Hawthorne, the investor must assume 280E taxation risk. Third, the price seems high, as 13% of the company is worth about $75 million. Fourth, it’s not clear to me that marrying a hemp operator with a subsidiary makes sense as I recall TILT Holdings.

I have followed Hawthorne Gardening for a long time and am glad that CEO Hagedorn and his team have gone ahead and purchased it and expanded it. The hemp industry has been struggling for about five years, and the big drop in Hawthorne Gardening’s revenue is not SMG’s fault in my opinion. It’s not clear to me how Vireo Growth will make it a better action, but I hope it has a good plan.

I continue to believe that investors should pay close attention to what is happening with shares in Vireo. This potential acquisition was not something that was discussed by analysts or investors, but today’s volume of 277 thousand shares was very low. Once again, Vireo, thanks to its aggressive M&A activity, has become the 7th largest MSO in the NCV Revenue Tracker. It remains very troubling to me that stocks are not earning a lot of interest.

Sincerely,

Alan:

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we published last week.

Exclusives

Canadian cannabis sales were abolished in November

Follow Alan for real-time updates X.com:. Share and discover industry news with like-minded people on the largest group of cannabis investors and entrepreneurs LinkedIn:.

View: Public Hemp Company Revenue and Earnings Trackingwhich ranks the highest-earning hemp stocks.

Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.